Organogenesis

Clinical trials sponsored by Organogenesis, explained in plain language.

Organogenesis ORGO NASDAQ

A regenerative medicine company specializing in wound care and surgical biologics.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Completed 2

Placental patch could speed healing of stubborn leg wounds

Disease control Recruiting now

This study tests whether a special wound dressing made from donated placental tissue, called NuShield, can help heal venous leg ulcers that won't close on their own. About 200 adults with these ulcers will receive either NuShield plus standard wound care or standard care alone. T…

Sponsor: Organogenesis • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

Organogenesis

Placental patch could speed healing of stubborn leg wounds